Remission · participants with acne
Herbal medicine showed no clear difference in secondary outcome: number of participants with remission (ITT‐best… compared with antibiotics (low certainty).
2 findings from 1 review
Intervention not reported
Cognitive function ‐ California Verbal Learning Test‐II short‐delay recall CVLT‐II SD recall1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Change in short‐term disability (function) FIM motor · 106 participants with primary brain tumour
1 finding from 1 review
Intervention not reported
Change in short‐term disability (cognition) FIM cognition · 106 participants with primary brain tumour
1 finding from 1 review
Intervention not reported
Change in short‐term psychological outcomes DASS (total) · 106 participants with primary brain tumour
1 finding from 1 review
Intervention not reported
Change in short‐term participation PIPP (total) · 106 participants with primary brain tumour
1 finding from 1 review
Intervention not reported
Change in short‐term QoL CARES‐SF (global) · 106 participants with primary brain tumour
1 finding from 1 review
Intervention not reported
Short‐term death ( · patients with acute ischaemic stroke
1 finding from 1 review
Intervention not reported
Short‐term disability assessed by the Barthel Index ( · patients with acute ischaemic stroke
1 finding from 1 review
Shoulder range of motion for forward flexion ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Lymphoedema ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
It is very uncertain whether the intervention changes lymphoedema ‐ short term (very low certainty).
1 finding from 1 review
Intervention not reported
Shoulder range of motion for abduction ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Intervention not reported
Shoulder range of motion for forward flexion ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Shoulder range of motion for abduction ‐ short term · patients at risk for secondary upper limb lymphoedema after breast cancer treatment
1 finding from 1 review
Clinically important response to treatment (short term) · patients with schizophrenia
Haloperidol showed no clear difference in clinically important response to treatment (short term) compared with first‐generation antipsychotics (low certainty).
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
Haloperidol showed no clear difference in leaving the study early due to any reason as a measure of overall… compared with first‐generation antipsychotics (low certainty).
1 finding from 1 review
Leaving the study early ‐ short term ‐ due to lack of efficacy · patients with schizophrenia
It is very uncertain whether haloperidol changes leaving the study early due to inefficacy of treatment as a measure… compared with first‐generation antipsychotics (very low certainty).
1 finding from 1 review
Leaving the study early ‐ due to adverse effects (short term) · patients with schizophrenia
It is very uncertain whether haloperidol changes leaving the study early due to adverse events as a measure of… compared with first‐generation antipsychotics (very low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · patients with schizophrenia
Haloperidol showed no clear difference in adverse effects: number of participants with at least one adverse… compared with first‐generation antipsychotics (low certainty).
1 finding from 1 review
Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia
It is very uncertain whether haloperidol changes adverse effects: extrapyramidal side effects: number of participants… compared with first‐generation antipsychotics (very low certainty).
1 finding from 1 review